Related Experiment Video
Updated: Mar 12, 2026
Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation
Robert J Donovan1, Calvin Choi2, Asghar Ali3
1Department of Medicine, Virginia Commonwealth University, McGuire VAMC, Richmond, VA, USA.
Insights
Patients with advanced liver disease often have asymptomatic cardiovascular risks. Pre-liver transplant screening methods vary due to unclear guidelines, highlighting the need for careful risk factor management for better outcomes.
Area of Science:
- Cardiology
- Hepatology
- Transplantation
Background:
- Advanced liver disease frequently coexists with cardiovascular risk factors.
- Many patients with liver disease remain asymptomatic regarding cardiac conditions.
- This complicates pre-transplant cardiovascular assessment.
Purpose of the Study:
- To review cardiovascular risk stratification in patients awaiting liver transplantation.
- To highlight the lack of standardized screening guidelines.
- To emphasize the importance of managing cardiovascular risk factors.
Main Methods:
- Review of current literature on cardiovascular risk assessment in liver transplant candidates.
- Analysis of various non-invasive and invasive cardiac screening modalities.
- Discussion of clinical practice variations and their implications.
Main Results:
- Multiple methods exist for cardiovascular risk stratification, including stress echocardiography, myocardial perfusion imaging, CT, and angiography.
- There is significant variation in practice regarding screening modality selection and patient selection.
- No clear consensus or guidelines exist for optimal screening strategies.
Conclusions:
- Standardized guidelines are needed for cardiovascular risk stratification before liver transplantation.
- Rigorous management of cardiovascular risk factors is crucial for post-transplant outcomes.
- Addressing these gaps can improve perioperative and long-term cardiovascular health in transplant recipients.
Abstract:
Patients with advanced liver disease have a high prevalence of cardiovascular risk factors, but many of them are asymptomatic. Cardiovascular risk stratification prior to liver transplant can be done by dobutamine stress echocardiography, stress myocardial perfusion imaging, cardiac computer tomography, and coronary angiography, but there are no clear recommendations regarding what method should be used and who should be screened. Because of this and because of inherent risk profile in this population, the variations in practice are significant. Careful screening and rigorous management of cardiovascular risk factors are important to ensure optimal cardiovascular outcomes in the immediate post-transplantation period and in the long term as well.
